Chai_2022_Front.Endocrinol.(Lausanne)_13_994944

Reference

Title : Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis - Chai_2022_Front.Endocrinol.(Lausanne)_13_994944
Author(s) : Chai S , Zhang R , Zhang Y , Carr RD , Zheng Y , Rajpathak S , Ji L
Ref : Front Endocrinol (Lausanne) , 13 :994944 , 2022
Abstract : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944
ESTHER : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944
PubMedSearch : Chai_2022_Front.Endocrinol.(Lausanne)_13_994944
PubMedID: 36313782

Related information

Citations formats

Chai S, Zhang R, Zhang Y, Carr RD, Zheng Y, Rajpathak S, Ji L (2022)
Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
Front Endocrinol (Lausanne) 13 :994944

Chai S, Zhang R, Zhang Y, Carr RD, Zheng Y, Rajpathak S, Ji L (2022)
Front Endocrinol (Lausanne) 13 :994944